Clinical trial
Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male…
NCT00404586 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00404586 |
|---|---|
| Title | Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber |
| Official title | A Randomised, Placebo-controlled, 4-period, Incomplete Block, Crossover Study of 7 Days Dosing of Intranasal GW784568X (100mcg, 200mcg and 400mcg od), Fluticasone Propionate (200mcg od) and Placebo (Blinded for GW784568X vs Placebo) to Evaluate the Efficacy and Safety Using an Environmental Chamber… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Perennial |
| Intervention type | Drug |
| Interventions | GW784568X, Fluticasone propionate, Placebo |
| Enrollment | 45 |
| Start date | Sep 11, 2006 |
| Primary completion | Jan 16, 2007 |
| Completion | Jan 16, 2007 |
| First posted | Nov 29, 2006 |
| Last update posted | Sep 12, 2017 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: